Nicolet Advisory Services’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$873K Sell
9,520
-520
-5% -$39.5K 0.06% 161
2025
Q3
$595K Sell
10,040
-1,165
-10% -$67.1K 0.05% 205
2025
Q2
$590K Buy
11,205
+669
+6% +$43.2K 0.05% 190
2025
Q1
$748K Buy
10,536
+2,152
+26% +$178K 0.07% 150
2024
Q4
$730K Buy
8,384
+1,175
+16% +$92.7K 0.07% 154
2024
Q3
$505K Buy
7,209
+435
+6% +$30.7K 0.05% 201
2024
Q2
$470K Buy
6,774
+1,009
+18% +$60.3K 0.05% 209
2024
Q1
$309K Buy
+5,765
New +$310K 0.03% 261

Other funds holding GMED

Nicolet Advisory Services's GMED Position: Q4 2025 in Review

Nicolet Advisory Services reduced its Globus Medical (GMED) stake by 5.2% in Q4 2025, selling an estimated $39.5K and leaving 9,520 shares worth $873K. The position accounts for 0.06% of the portfolio, ranked #161.

Nicolet Advisory Services first reported a position in GMED in Q1 2024 and has held it in 8 quarters since. 561 funds tracked by Wall St. Rank hold GMED as of Q4 2025.

  • Nicolet Advisory Services held 9,520 shares of Globus Medical worth $873K as of Q4 2025.
  • Nicolet Advisory Services sold 520 Globus Medical shares in Q4 2025, an estimated $39.5K.
  • Globus Medical made up 0.06% of Nicolet Advisory Services's portfolio in Q4 2025, its #161 holding.
  • Nicolet Advisory Services first reported a position in Globus Medical in Q1 2024 and has held it in 8 quarters since.
  • 561 funds tracked by Wall St. Rank held Globus Medical as of Q4 2025.

Based on Nicolet Advisory Services's 13F filing for Q4 2025, filed 13 Feb 2026.